Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.

Summary Expression Phenotypes Gene Literature (234) GO Terms (11) Nucleotides (370) Proteins (50) Interactants (1557) Wiki
XB-GENEPAGE-484285

Papers associated with tp53



???displayGene.coCitedPapers???
22 ???displayGene.morpholinoPapers???

???pagination.result.count???

???pagination.result.page??? 1 2 3 4 5 ???pagination.result.next???

Sort Newest To Oldest Sort Oldest To Newest

referenced by:

Cloning and characterization of a cDNA from Xenopus laevis coding for a protein homologous to human and murine p53., Soussi T, Caron de Fromentel C, Méchali M, May P, Kress M., Oncogene. March 1, 1987; 1 (1): 71-8.

Two distinct regions of the murine p53 primary amino acid sequence are implicated in stable complex formation with simian virus 40 T antigen., Jenkins JR, Chumakov P, Addison C, Stürzbecher HW, Wade-Evans A., J Virol. October 1, 1988; 62 (10): 3903-6.

Evolutionary conservation of the biochemical properties of p53: specific interaction of Xenopus laevis p53 with simian virus 40 large T antigen and mammalian heat shock proteins 70., Soussi T, Caron de Fromentel C, Stürzbecher HW, Ullrich S, Jenkins J, May P., J Virol. September 1, 1989; 63 (9): 3894-901.

Tumor suppressor genes., Levine AJ., Bioessays. February 1, 1990; 12 (2): 60-6.

Genes and mechanisms involved in early embryonic development in Xenopus laevis., Méchali M, Almouzni G, Andéol Y, Moreau J, Vriz S, Leibovici M, Hourdry J, Géraudie J, Soussi T, Gusse M., Int J Dev Biol. March 1, 1990; 34 (1): 51-9.

Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form., Gannon JV, Greaves R, Iggo R, Lane DP., EMBO J. May 1, 1990; 9 (5): 1595-602.

Genetic and immunochemical analysis of mutant p53 in human breast cancer cell lines., Bartek J, Iggo R, Gannon J, Lane DP., Oncogene. June 1, 1990; 5 (6): 893-9.

p53 mutations in human cancers., Hollstein M, Sidransky D, Vogelstein B, Harris CC., Science. July 5, 1991; 253 (5015): 49-53.

Mutant conformation of p53. Precise epitope mapping using a filamentous phage epitope library., Stephen CW, Lane DP., J Mol Biol. June 5, 1992; 225 (3): 577-83.

Identification of RNA-binding proteins specific to Xenopus Eg maternal mRNAs: association with the portion of Eg2 mRNA that promotes deadenylation in embryos., Legagneux V, Bouvet P, Omilli F, Chevalier S, Osborne HB., Development. December 1, 1992; 116 (4): 1193-202.

The Ets family of transcription factors., Wasylyk B, Hahn SL, Giovane A., Eur J Biochem. January 15, 1993; 211 (1-2): 7-18.

Stabilization and expression of high levels of p53 during early development in Xenopus laevis., Tchang F, Gusse M, Soussi T, Méchali M., Dev Biol. September 1, 1993; 159 (1): 163-72.

The canine p53 gene is subject to somatic mutations in thypoid carcinoma., Devilee P, Van Leeuwen IS, Voesten A, Rutteman GR, Vos JH, Cornelisse CJ., Anticancer Res. January 1, 1994; 14 (5A): 2039-46.

Overexpression of wild-type p53 interferes with normal development in Xenopus laevis embryos., Hoever M, Clement JH, Wedlich D, Montenarh M, Knöchel W., Oncogene. January 1, 1994; 9 (1): 109-20.

A novel p53 mutant in human breast cancer revealed by multiple SSCP analysis., Nigro V, Napolitano M, Abbondanza C, Medici N, Puca AA, Schiavulli M, Armetta I, Moncharmont B, Puca GA, Molinari AM., Cancer Lett. April 29, 1994; 79 (1): 73-5.

Xenopus p53 is biochemically similar to the human tumour suppressor protein p53 and is induced upon DNA damage in somatic cells., Cox LS, Midgley CA, Lane DP., Oncogene. October 1, 1994; 9 (10): 2951-9.

Cip1 blocks the initiation of DNA replication in Xenopus extracts by inhibition of cyclin-dependent kinases., Strausfeld UP, Howell M, Rempel R, Maller JL, Hunt T, Blow JJ., Curr Biol. October 1, 1994; 4 (10): 876-83.

Functional characterization of Xenopus laevis p53: evidence of temperature-sensitive transactivation but not of repression., Ridgway PJ, Soussi T, Braithwaite AW., J Virol. November 1, 1994; 68 (11): 7178-87.

Expression of a homologue of the deleted in colorectal cancer (DCC) gene in the nervous system of developing Xenopus embryos., Pierceall WE, Reale MA, Candia AF, Wright CV, Cho KR, Fearon ER., Dev Biol. December 1, 1994; 166 (2): 654-65.              

Cip1 inhibits DNA replication but not PCNA-dependent nucleotide excision-repair., Shivji MK, Grey SJ, Strausfeld UP, Wood RD, Blow JJ., Curr Biol. December 1, 1994; 4 (12): 1062-8.

Fission yeast tmsl protein abrogates normal development in Xenopus laevis embryos., Wagner P, Hoever M, Appel K, Knöchel W, Montenarh M., Rouxs Arch Dev Biol. January 1, 1995; 204 (3): 198-202.

Xenopus laevis p53 protein: sequence-specific DNA binding, transcriptional regulation and oligomerization are evolutionarily conserved., Wang Y, Farmer G, Soussi T, Prives C., Oncogene. February 16, 1995; 10 (4): 779-84.

Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA., Chen J, Jackson PK, Kirschner MW, Dutta A., Nature. March 23, 1995; 374 (6520): 386-8.

A direct effect of activated human p53 on nuclear DNA replication., Cox LS, Hupp T, Midgley CA, Lane DP., EMBO J. May 1, 1995; 14 (9): 2099-105.

The spectrum of mutations at the p53 locus. Evidence for tissue-specific mutagenesis, selection of mutant alleles, and a "gain of function" phenotype., Levine AJ, Wu MC, Chang A, Silver A, Attiyeh EF, Lin J, Epstein CB., Ann N Y Acad Sci. September 30, 1995; 768 111-28.

Tumour suppressor gene p53 in the horse: identification, cloning, sequencing and a possible role in the pathogenesis of equine sarcoid., Bucher K, Szalai G, Marti E, Griot-Wenk ME, Lazary S, Pauli U., Res Vet Sci. September 1, 1996; 61 (2): 114-9.

Cyclin-binding motifs are essential for the function of p21CIP1., Chen J, Saha P, Kornbluth S, Dynlacht BD, Dutta A., Mol Cell Biol. September 1, 1996; 16 (9): 4673-82.

B-Myb, a repressed trans-activating protein., Ansieau S, Kowenz-Leutz E, Dechend R, Leutz A., J Mol Med (Berl). January 1, 1997; 75 (11-12): 815-9.

Biochemical properties of Xenopus laevis p53., Hoever M, Herrmann C, Montenarh M., Int J Oncol. January 1, 1997; 10 (1): 195-203.

Conservation of structural domains and biochemical activities of the MDM2 protein from Xenopus laevis., Marechal V, Elenbaas B, Taneyhill L, Piette J, Mechali M, Nicolas JC, Levine AJ, Moreau J., Oncogene. March 27, 1997; 14 (12): 1427-33.

Cloning of the p53 tumor suppressor gene from the Japanese medaka (Oryzias latipes) and evaluation of mutational hotspots in MNNG-exposed fish., Krause MK, Rhodes LD, Van Beneden RJ., Gene. April 11, 1997; 189 (1): 101-6.

p21CIP1 and Cdc25A: competition between an inhibitor and an activator of cyclin-dependent kinases., Saha P, Eichbaum Q, Silberman ED, Mayer BJ, Dutta A., Mol Cell Biol. August 1, 1997; 17 (8): 4338-45.

A functional analysis of p53 during early development of Xenopus laevis., Amariglio F, Tchang F, Prioleau MN, Soussi T, Cibert C, Méchali M., Oncogene. October 1, 1997; 15 (18): 2191-9.

p53 activity is essential for normal development in Xenopus., Wallingford JB, Seufert DW, Virta VC, Vize PD., Curr Biol. October 1, 1997; 7 (10): 747-57.            

[A large T-antigen of SV40 virus: involvement in replication of cellular DNA and interactions with nuclear proteins]., Vasetskiĭ ES, Meshali M., Ontogenez. January 1, 1998; 29 (3): 170-7.

Regulation of the specific DNA binding activity of Xenopus laevis p53: evidence for conserved regulation through the carboxy-terminus of the protein., Bessard AC, Garay E, Lacronique V, Legros Y, Demarquay C, Houque A, Portefaix JM, Granier C, Soussi T., Oncogene. February 19, 1998; 16 (7): 883-90.

Overexpression of a novel Xenopus rel mRNA gene induces tumors in early embryos., Yang S, Lockwood A, Hollett P, Ford R, Kao K., J Biol Chem. May 29, 1998; 273 (22): 13746-52.                

p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities., Yang A, Kaghad M, Wang Y, Gillett E, Fleming MD, Dötsch V, Andrews NC, Caput D, McKeon F., Mol Cell. September 1, 1998; 2 (3): 305-16.

Production of a polyclonal antibody raised against recombinant flounder p53 protein., Cachot J, Galgani F, Vincent F., Comp Biochem Physiol C Pharmacol Toxicol Endocrinol. October 1, 1998; 120 (3): 351-6.

Ras and p53 intracellular targeting with recombinant single-chain Fv (scFv) fragments: a novel approach for cancer therapy?, Cochet O, Gruel N, Fridman WH, Teillaud JL., Cancer Detect Prev. January 1, 1999; 23 (6): 506-10.

A leucine-rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking., Stommel JM, Marchenko ND, Jimenez GS, Moll UM, Hope TJ, Wahl GM., EMBO J. March 15, 1999; 18 (6): 1660-72.

Influence of the N-terminal region on the oligomerisation between human and Xenopus laevis p53., Chène P., J Mol Biol. May 21, 1999; 288 (5): 883-90.

Nuclear import of p53 during Xenopus laevis early development in relation to DNA replication and DNA repair., Tchang F, Méchali M., Exp Cell Res. August 25, 1999; 251 (1): 46-56.

T-antigen interactions with chromatin and p53 during the cell cycle in extracts from xenopus eggs., Vassetzky YS, Tchang F, Fanning E, Méchali M., J Cell Biochem. November 1, 1999; 75 (2): 288-99.

The amyloid beta peptide abeta (25-35) induces apoptosis independent of p53., Blasko I, Wagner M, Whitaker N, Grubeck-Loebenstein B, Jansen-Dürr P., FEBS Lett. March 24, 2000; 470 (2): 221-5.

A novel smad nuclear interacting protein, SNIP1, suppresses p300-dependent TGF-beta signal transduction., Kim RH, Wang D, Tsang M, Martin J, Huff C, de Caestecker MP, Parks WT, Meng X, Lechleider RJ, Wang T, Roberts AB., Genes Dev. July 1, 2000; 14 (13): 1605-16.            

Form of human p53 protein during nuclear transport in Xenopus laevis embryos., Hara T, Arai K, Koike K., Exp Cell Res. July 10, 2000; 258 (1): 152-61.

Reconstitution of an ATM-dependent checkpoint that inhibits chromosomal DNA replication following DNA damage., Costanzo V, Robertson K, Ying CY, Kim E, Avvedimento E, Gottesman M, Grieco D, Gautier J., Mol Cell. September 1, 2000; 6 (3): 649-59.

Cell-cycle regulation of the p53-inducible gene B99., Collavin L, Monte M, Verardo R, Pfleger C, Schneider C., FEBS Lett. September 8, 2000; 481 (1): 57-62.

The Mdm2 gene of zebrafish (Danio rerio): preferential expression during development of neural and muscular tissues, and absence of tumor formation after overexpression of its cDNA during early embryogenesis., Thisse C, Neel H, Thisse B, Daujat S, Piette J., Differentiation. October 1, 2000; 66 (2-3): 61-70.

???pagination.result.page??? 1 2 3 4 5 ???pagination.result.next???